Q1 2019 Holdings
Filed 2019-05-15 | 105 holdings | $3.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2019-05-16) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $331.1K | 3,758,662 | 9.3% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $294.3K | 21,639,486 | 8.3% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $292.5K | 5,525,726 | 8.3% |
| Zogenix Inc | COM | 98978L204 | $212.9K | 3,869,491 | 6.0% |
| Amarin Corporation PLC | SPONS ADR NEW | 023111206 | $135.8K | 6,540,957 | 3.8% |
| Ascendis Pharma A S(ASND)A | SPONSORED ADR | 04351P101 | $131.0K | 1,113,328 | 3.7% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $116.4K | 12,235,811 | 3.3% |
| Meiragtx Holdings PLC(MGTX) | COM | G59665102 | $103.5K | 6,007,746 | 2.9% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $103.1K | 4,228,900 | 2.9% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $101.7K | 1,271,054 | 2.9% |
| Quotient Technology Inc(QUOTUSD) | COM | 749119103 | $97.2K | 10,789,054 | 0.0% |
| Quotient LTDA | SHS | G73268107 | $97.2K | 10,789,054 | 2.7% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $85.3K | 1,164,382 | 2.4% |
| Retrophin Inc | COM | 761299106 | $69.1K | 3,054,707 | 2.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $65.7K | 1,145,726 | 1.9% |
| Merit Medical Systems Inc(MMSI) | COM | 589889104 | $65.1K | 1,053,098 | 1.8% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM | 040047607 | $62.8K | 1,400,171 | 1.8% |
| Athenex Inc(ATNXEUR) | COM | 04685N103 | $62.4K | 5,096,022 | 1.8% |
| Crinetics Pharmaceuticals Inc(CRNX)A | COM | 22663K107 | $58.9K | 2,587,953 | 1.7% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $55.9K | 4,212,821 | 1.6% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $54.9K | 1,704,330 | 1.5% |
| Myokardia Inc | COM | 62857M105 | $51.4K | 988,511 | 1.4% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $50.9K | 2,171,918 | 1.4% |
| Allogene Therapeutics Inc(ALLO)A | COM | 019770106 | $44.6K | 1,543,790 | 1.3% |
| VBI Vaccines Inc(VAC2USD) | COM | 91822J103 | $42.6K | 23,951,556 | 1.2% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $41.8K | 2,875,000 | 1.2% |
| Verrica Pharmaceuticals Inc | COM | 92511W108 | $38.5K | 3,410,412 | 1.1% |
| Solid Biosciences Inc | COM | 3422E1055 | $36.1K | 3,927,222 | 1.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $35.5K | 4,805,650 | 1.0% |
| Kadmon Holdings Inc(KDMN) | COM | 48283N106 | $34.8K | 13,165,746 | 1.0% |
| Cytomx Therapeutics Inc(CTMX)A | COM | 23284F105 | $34.1K | 3,173,923 | 1.0% |
| Neptune Wellness Solutions Inc | COM | 64079L105 | $28.4K | 8,891,452 | 0.8% |
| Aldeyra Therapeutics Inc(ALDX)A | COM | 01438T106 | $27.9K | 3,085,458 | 0.8% |
| Dova Pharmaceuticals Inc(DOVA) | COM | 25985T102 | $27.8K | 3,125,851 | 0.8% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $27.5K | 495,000 | 0.8% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $26.6K | 2,204,641 | 0.8% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $26.1K | 416,949 | 0.7% |
| Protagonist Therapeutics Inc | COM | 4366E1029 | $26.0K | 2,071,297 | 0.7% |
| Adma Biologics Inc(ADMA)A | COM | 000899104 | $24.7K | 6,521,102 | 0.7% |
| Vapotherm Inc | COM | 922107107 | $24.5K | 1,246,315 | 0.7% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $20.5K | 3,135,199 | 0.6% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $18.1K | 289,857 | 0.5% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $17.5K | 4,661,824 | 0.5% |
| Axonics Modulation Technologies Inc(AXNX*) | COM | 05465P101 | $16.4K | 685,756 | 0.5% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $16.1K | 686,992 | 0.5% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $15.0K | 200,000 | 0.4% |
| Bausch Health COS Inc(BHC)A | COM | 071734107 | $14.8K | 600,000 | 0.4% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $14.8K | 614,242 | 0.4% |
| Aquestive Therapeutics Inc | COM | 3843E1047 | $14.6K | 2,113,400 | 0.4% |
| Akebia Therapeutics Inc(AKBA)A | COM | 00972D105 | $14.0K | 1,703,440 | 0.4% |